Hualan Biological Vaccine Inc. (SHE:301207)

Hualan Biological Vaccine Statistics

Total Valuation

SHE:301207 has a market cap or net worth of CNY 9.72 billion. The enterprise value is 6.72 billion.

Market Cap	9.72B
Enterprise Value	6.72B

Important Dates

The last earnings date was Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	Jun 14, 2024

Share Statistics

SHE:301207 has 595.00 million shares outstanding. The number of shares has decreased by -0.93% in one year.

Current Share Class	595.00M
Shares Outstanding	595.00M
Shares Change (YoY)	-0.93%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	3.30%
Float	79.97M

Valuation Ratios

The trailing PE ratio is 48.80 and the forward PE ratio is 15.26.

PE Ratio	48.80
Forward PE	15.26
PS Ratio	8.69
PB Ratio	1.61
P/TBV Ratio	1.61
P/FCF Ratio	28.75
P/OCF Ratio	26.33
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.19, with an EV/FCF ratio of 19.90.

EV / Earnings	33.67
EV / Sales	6.02
EV / EBITDA	29.19
EV / EBIT	74.72
EV / FCF	19.90

Financial Position

The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.05.

Current Ratio	3.74
Quick Ratio	3.38
Debt / Equity	0.05
Debt / EBITDA	1.30
Debt / FCF	0.89
Interest Coverage	14.79

Financial Efficiency

Return on equity (ROE) is 3.23% and return on invested capital (ROIC) is 0.87%.

Return on Equity (ROE)	3.23%
Return on Assets (ROA)	0.74%
Return on Invested Capital (ROIC)	0.87%
Return on Capital Employed (ROCE)	1.48%
Revenue Per Employee	1.49M
Profits Per Employee	266,983
Employee Count	748
Asset Turnover	0.15
Inventory Turnover	0.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.33% in the last 52 weeks. The beta is 0.78, so SHE:301207's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-26.33%
50-Day Moving Average	16.68
200-Day Moving Average	17.84
Relative Strength Index (RSI)	52.01
Average Volume (20 Days)	1,642,751

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301207 had revenue of CNY 1.12 billion and earned 199.70 million in profits. Earnings per share was 0.33.

Revenue	1.12B
Gross Profit	831.09M
Operating Income	90.00M
Pretax Income	206.58M
Net Income	199.70M
EBITDA	230.38M
EBIT	90.00M
Earnings Per Share (EPS)	0.33

Balance Sheet

The company has 3.29 billion in cash and 300.00 million in debt, giving a net cash position of 2.99 billion or 5.03 per share.

Cash & Cash Equivalents	3.29B
Total Debt	300.00M
Net Cash	2.99B
Net Cash Per Share	5.03
Equity (Book Value)	6.05B
Book Value Per Share	10.16
Working Capital	3.71B

Cash Flow

In the last 12 months, operating cash flow was 369.02 million and capital expenditures -31.05 million, giving a free cash flow of 337.98 million.

Operating Cash Flow	369.02M
Capital Expenditures	-31.05M
Free Cash Flow	337.98M
FCF Per Share	0.57

Margins

Gross margin is 74.35%, with operating and profit margins of 8.05% and 17.86%.

Gross Margin	74.35%
Operating Margin	8.05%
Pretax Margin	18.48%
Profit Margin	17.86%
EBITDA Margin	20.61%
EBIT Margin	8.05%
FCF Margin	30.23%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.23%.

Dividend Per Share	0.20
Dividend Yield	1.23%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	3
Payout Ratio	182.00%
Buyback Yield	0.93%
Shareholder Yield	2.16%
Earnings Yield	2.06%
FCF Yield	3.48%

Stock Splits

The last stock split was on June 7, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 7, 2023
Split Type	Forward
Split Ratio	1.5

Scores

SHE:301207 has an Altman Z-Score of 6.1.

Altman Z-Score	6.1
Piotroski F-Score	n/a